Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- COVID-19: Australia to end mandatory isolation
- Time to address mental health issues in the workplace, UN agencies urge
- Build momentum to ‘finish the job’ and end COVID-19 pandemic, Guterres urges
- Noncommunicable diseases now ‘top killers globally’ – UN health agency report
- Seven Ebola cases, one death confirmed in Uganda, WHO scales up response